Fertility Startup Pluro Raises ₹125 Cr in Series A Funding Led by Bessemer Venture Partners at ₹ 1,000 Crore Valuation

Pluro Fertility and IVF, a healthcare partnership platform, today announced that it has raised Rs. 125 Crore in Series A funding round led by Bessemer Venture Partners at a valuation of Rs. 1,000 Crores. The round marks a key milestone in Pluro's mission to partner with India's most accomplished fertility specialists and help millions of Indian women and men realize their dream of parenthood. Prominent angels such as Vikram Chatwal (MediAssist), Dharmil Sheth & Hardik Dedhia (PharmEasy/All Home), Salil Musale (Astarc Ventures), Shalibhadra Shah and Niket Shah (Motilal Oswal), Karan Kapur (K Hospitality), also participated in this round.

Founded in 2025 by Dr. Jaydeep Tank, Dr. Parikshit Tank, and Dr. Bhaskar Shah, Pluro partners with successful independent IVF specialists across India through a clinical partnership model that preserves doctor autonomy while offering centralized operational support. This enables clinicians to focus entirely on patient outcomes while scaling their practices sustainably. Pluro plans to have 25 fertility centers pan-India by March 2026, each in partnership with a leading fertility specialist with at-least a decade of exceptional clinical expertise.

Dr. Jaydeep Tank, co-founder & CEO of Pluro Fertility

“India’s most respected fertility specialists have spent decades building trusted patient relationships and delivering consistent clinical outcomes. Operational bottlenecks and bandwidth limit their ability to scale and invest in technology and infrastructure. Pluro solves for this and enables them to serve couples truly becoming partners in the journey to Parenthood enabled by Tech, research, great infrastructure and state of the art care” said Dr. Jaydeep Tank, co-founder & CEO of Pluro Fertility, on behalf of the Founders. Pluro supports everything outside the consultation room - so doctors can do what they do best: help create families.”

Pluro manages all non-clinical functions across partner clinics, including practice management, technology, compliance and marketing. The platform provides each partner doctor with equity participation, aligning incentives across the network and enabling wealth creation for doctors as Pluro grows.

Pluro plans to have a pan-India presence with the initial 25 fertility partners scaling up to 100+ clinics within 3 years. Pluro will use the fresh capital to expand its network presence, invest in technology, and deepen clinical capabilities in advanced reproductive science.

“India needs scalable, credible fertility care now more than ever,” said Nithin Kaimal, Partner and COO at Bessemer Venture Partners India. “Pluro brings together world-class medical leadership and a thoughtful partnership model for doctors, backed by strong execution. We are excited to partner with them to build India’s leading fertility platform.”

Pluro brings together three industry leaders with deep medical and operational expertise:

• Dr. Jaydeep Tank: Leading Gynaeocologist, amongst the earliest adopters of IVF in India; helped establish 20+ clinics, Immediate Past President of FOGSI.,
• Dr. Parikshit Tank: A Leading Gynaecologist and IVF specialist with over 80 peer-reviewed publications and author of four medical textbooks Deputy Secretary General of FOGSI.,
• Dr. Bhaskar Shah: Leading Cardiologist and Co-founder of Asian Heart Institute & Co-Founder, Board Member and Head of Dept. of Cardiology of Jupiter Hospitals (listed healthcare company)

Kedaara Capital Invests in Oasis Fertility, an Innovator and One of the Market Leaders in Assisted Reproductive Technology (ART) Industry

Dr Durga Rao, Co-Founder & Medical Director, Oasis Fertility

The investment aims to strengthen Oasis’ organic expansion and accelerate inorganic partnerships across India and adjacent markets to further its mission of being a research-driven, clinical excellence-oriented fertility platform

Oasis Fertility, one of India’s most clinically advanced fertility chains, today announced an investment from Kedaara Capital, a leading private equity firm in India, for a significant minority stake in the company. This is Kedaara’s second investment in the single speciality healthcare segment. With this USD 50 mn transaction and a commitment to deploy further capital for strategic acquisitions, Kedaara aims to support and fuel Oasis’ growth towards realizing its vision of becoming the most respected and leading fertility chain in India and adjacent markets. The transaction will also provide an exit to InvAscent, who invested in the company in 2016.

Founded in 2009, Oasis has scaled to a network of 26 clinics across 16 cities while doubling its revenues in the last 3 years. Oasis’ scientific and excellence-oriented culture has enabled it to bring pioneering treatments and procedures to the fertility market which is reflected in its high success rates. Further, Oasis enjoys a strong reputation for handling complex cases and delivering successful outcomes in patients with a history of unsuccessful IVF treatments. The company also runs a unique, accredited in-house training academy, Oasis School for Human Embryology and Reproductive Medicine (OSHERM), that has trained over 200 medical professionals and published over 60 research papers. Oasis is also known for its highest standards of ethics in the industry and has launched a first of its kind andrology (male infertility) practice, known as AndroLife.

Kiran Gadela, Co-Founder & Managing Director, Oasis Fertility said, “Kedaara’s strategic partnership with Oasis is a significant milestone in our growth journey, and further cements our position as one of the most trusted providers of fertility treatments in India. We are delighted and excited about the prospects of leveraging Kedaara’s in-depth understanding of the sector and the Indian market and their experience in supporting & scaling marquee healthcare assets. We look forward to this partnership as we embark on a journey to pursue attractive synergistic acquisitions and create a leading fertility platform in India and South Asia to further our core purpose of helping couples achieve parenthood. With the help of our futuristic tech platform, we feel confident about executing on that strategy. We also thank the InvAscent team for their support over the past 6 years.”

Dr Durga Rao, Co-Founder & Medical Director, Oasis Fertility said, “Oasis’ patient-centric approach has been a symbol of excellence and transparency and our in-house training program has been the preferred choice for clinical talent in the country. We are delighted to welcome Kedaara Capital as a strategic partner on our mission to provide accessible, compassionate, and high-quality healthcare and to bring the joy of parenthood to couples across the country.”

According to the World Health Organisation, infertility affects 15% of reproductive-aged couples worldwide. Moreover, research suggests that the ovaries of Indian women age nearly six years earlier than their Caucasian counterparts, leading to earlier onset of infertility among Indian women. A confluence of environmental and lifestyle factors has further increased the incidence of fertility in India over the years. Infertility can cause tremendous emotional and psychological distress amongst couples. However, with timely medical care from providers like Oasis Fertility, many couples battling infertility are able to conceive and become parents.

Nishant Sharma, CIO & Managing Partner of Kedaara Capital said, “Oasis has created a scalable, replicable model and espouses a unique culture with clinical excellence and ethics at its core. Moreover, its highly experienced and well-trained clinical team has become a hallmark of excellence in the medical fraternity. We are excited to partner with Dr. Durga Rao, Kiran Gadela and the Oasis team in the journey to bring high quality, pioneering approach towards fertility treatment to people across India and adjacent markets. Kedaara, with its operational expertise, experience in healthcare and availability of additional capital, will support Oasis in the next step of its growth journey and in realising its vision of becoming the leading fertility chain in the country and adjacent geographies. We look forward to partnering with like-minded and culturally aligned IVF clinicians and practices across India and South Asia to form a fertility platform with patient centricity and clinical excellence as its bed rock.”

Vishy Chebrol, Co-Founder, CIO and Managing Director, InvAscent said, “We partnered with Dr Durga & Kiran in 2016 when Oasis was largely a Hyderabad focussed fertility chain. Since then, Oasis has successfully navigated the challenges of scaling. Along its journey, Oasis has gifted the joy of parenthood to thousands of couples. We wish them the absolute best in their journey to scale Oasis across the country.”

O3 Capital acted as the exclusive financial advisor for the transaction and Samvad Partners was the legal counsel to Oasis Fertility. Quillon Partners acted as legal counsel to InvAscent and Veritas Legal acted as legal counsel to Kedaara Capital.

About Oasis Fertility

Bootstrapped and founded in 2009 by Dr Durga Rao and Kiran Gadela, Oasis Fertility (“Oasis”) is amongst the most scaled-up IVF chains in India. Having started with its first centre in Banjara Hills, Hyderabad, Oasis today has 26 centres in 16 cities across the country. Oasis is a pure-play fertility player offering various assisted reproductive therapies such as OI/TI, IUI and IVF along with male infertility treatments.

Dr Durga is a renowned fertility specialist with 17 years of experience in the industry (including 8 years as a practising IVF specialist in NHS, UK and Canada) and heads the medical function Oasis as its Medical Director. She is passionate about the field of reproductive medicine, has several research publications in her name, and has trained over 100 medical professionals.

Kiran is first generation entrepreneur with over 25 years of work experience and has built the company from scratch. As the Managing Director of the company, he is responsible for the overall strategy and growth of the organization. Prior to starting Oasis, Kiran was an IT and management professional, having worked with large global corporations for over 12 years.

Oasis has played a pioneering role in the adoption of advanced equipment and therapies such, mTESA, ERA, PGT/PGS. Deeply committed to providing high quality care, Oasis’ systems and processes are aligned with global best practises thereby establishing a reputation for its ability to manage complex cases as it continues its mission to enhance the quality of care and bringing the joy of parenthood to couples across the country.

Website: www.oasisindia.in

About Kedaara

Kedaara is an operationally oriented private equity firm pursuing control and minority investment opportunities in India. It currently advises / manages over ~US$ 3.6 billion through investments in several market leading businesses across a variety of sectors including consumer, financial services, pharma/healthcare, technology / business services and industrials. Kedaara’s operating partner model comprising former CEOs with proven track records of building market leading businesses enabling them to realize their full potential. 

Since its inception, Kedaara has remained singularly dedicated to its stated strategy of focusing on investments built through trust-based relationships with best-in-class entrepreneurs and management teams across secular fast growing end markets. Kedaara was co-founded by Sunish Sharma, Nishant Sharma and Manish Kejriwal and combines the strengths of a well-networked, highly experienced local investing and operating team, with the experience of their strategic partner, Clayton, Dubilier & Rice, a global private equity firm whose investment model blends financial skills with operating expertise. For further information about Kedaara, please visit: https://kedaara.com

This Mompreneur is Offering Friendly Platform for Women with Infertility by Disrupting $775Mn IVF Market

At the age of 23 Gitanjali Banerjee got married to the man in Olive Green and from here her journey to unknown and unexplored began. As every other married girl Gitanjali next phase after marriage was the phase of being mother. But for her it turns into pain of 10 long and gruelling years of fighting infertility. Post 5 miscarriages, 3 molar pregnancies, 1 failed IVF, a brush with ovarian cancer; she finally succeeded on second IVF attempt.

I had a long and roller coaster journey towards motherhood. The pain and the social disdain that a woman undergoes during infertility journey is unimaginable and humiliating. Society, on the other hand has no idea about the pain of infertility and people end up hurting by passing shallow comments. It is startling that there is no neutral platform and especially no woman who comes up and says, “Yes, I have gone through it, I know it is not easy but got to keep going”. 1 in every 4 couple in India is fighting some or the other form of infertility. There was a need to come out of the infertility closet,” shares Gitanjali.

For Gitanjali her personal fear was the biggest challenge. But once, she overcame it and shared her story with people, it simply warmed up her which landed her into the land of entrepreneurship. She founded inFertility Dost to reach out to women who suffer in silence, bring real stories, make the society aware and acknowledge the pain, and most importantly to help patients find the right doctor.

“No, entrepreneurship was not in my mind but it became the need, a tool to reach out to millions of people who were sailing in the same boat like me. It became a tool for help others and thus social entrepreneurship project, inFertility Dost came happened to me,” says Gitanjali.

Bridging The Gap

It is believed that nearly 15% of the Indian population suffers from some form of infertility. Research in fact indicates that India has witnessed a 20-30% surge in infertility cases in the past 5 years. The volume of people affected by it sums up to be more than 150 million. Every year 10 million new cases are adding up in India. Gitanjali with her startup aims to cater this growing market. The target group for them including preventive healthcare of infertility stands at 460 million.



InfertilityDost, is an online platform that facilitates couples to brave infertility with support and knowledge. They hold hand, facilitate right guidance so that couples can take good decisions and stay away from misleading advertisements and fraud clinics, answer their queries by connecting them to experts, keep them motivated throughout this tough phase of life, reinforcing their strength and hope and enable them to fight with society’s stereotypes and prejudices.

“InfertilityDost fills the need to handhold a patient through the journey and bring everything under one portal to save time, cost and harassment. The social impact that we can create is huge leading empowerment of women. Also, the IVF market currently is unregulated, unorganized and not transparent. We aim to digitize atleast 10% of this market,” says Gitanjali.

InfertilityDost aims to build a complete ecosystem for infertility patients making support and knowledge accessible so that they can stay informed. There are many pain points in the journey of an infertility patients and InfertilityDost wishes to handhold at each stage, guide and provide services that can alleviate the ignorance and discomfort faced.

Currently, for Gitanjali the challenge is to find the right fit team where she is struggling.

Providing Emotional Connect

Startup is a patient-provider platform exclusively for the infertility and IVF patients. inFertilityDost provides handholding for patients with care, support, information and ancillary preparatory services.

“Our patient base is approx 5000. We conduct around 5 awareness campaigns and talks per month. We are focussed on building a community right now. We plan to leverage this power soon,” says Gitanjali.

Competing with startup like Practo, Gitajali says, “Though they are just listing and there is no emotional connect with patients. Our differentiation point is our community building, content and accessibility of all information in one portal.”

Future Plans:

Gitanjali believes that by using artificial intelligence (AI) as a tool can to do predictive analysis and serve the patients better in customized environment. Currently been incubated at IIT Delhi under their WEE program ( Women empowerment entrepreneurship), Gitanjali is looking to raise Rs 50 lakhs. Being India as their core focus, inFertilityDost get a lot of traffic from metros especially Bengaluru, Gurgaon and Delhi. Startup plans to expand its geographical reach to Tier 2 and Tier 3 cities where treatment information is hardly available.

“Egg and sperm donation market is marred with irregularities that often lead to violation of government rules. Often, samples are passed without proper medical testing leading to occurrence of genetic and other problems in IVF children at a later stage. We aim to bring pre-tested and verified samples to the market. We will take this awareness among corporate to help them balance their biological clock and career better with options of freezing,” concludes Gitanjali.

Sector Overview:

Rise in the number of couples suffering from infertility, owing to urbanisation, pollution, stress, and lifestyle patterns has led to rapid growth of Indian market for IVF services. If we look at the figures stated by a report of Allied Market Research (AMR), IVF services market in India is projected to reach US$ 775.9 million by 2022, registering a CAGR of 16.6 percent from 2016 to 2022.

Further, owing to low service cost and availability of skilled workforce, India is becoming one of the preferred destination for medical tourism. Cost of IVF treatment for infertility in India is one-fourth as compared to the developed countries, as per the government of India’s Medical Tourism Department.

Not only this, clinics operating in the UK, Australia, Spain, Denmark, Israel, and France find it difficult to provide their patients with donor egg IVF services. Therefore, these patients approach India, where donor egg IVF is more convenient. There are several hospital chains like Apollo; Sun Pharmaceuticals Industries Ltd; Cadila Healthcare Ltd; Trivector Origio Scientific; Lab IVF Asia Pte Ltd; LG Life Sciences;, Bourn Hall Clinic; Morpheus IVF Fertility Center; Cloudnine, a multi-city hospital chain for women and children specialising in obstetrics, gynaecology, fertility, and neonatology have come up to capitalise this untouched market.

Despite of all these encouraging factor, IVF market struggle to grow due to ethical and legal issues related to surrogacy. Apart from this, lack of established regulations and reimbursement policies leading to manipulative practices (such as sex identification and sex selection), also restrains the IVF market growth.

But mushrooming of startups like inFertilityDost has come as ray of hope of the IVF market. Now time will tell, how best these startups can capture Indian and market and provide people with sigh of relief.